Junzheng Yang

Summary

Has been nominated and selected as the Full Membership in Sigma Xi, The  Scientific Research Honor Society of America in 2024;
Invited expert for the 2022, 2023, and 2024 Times Higher Education Global Academic Reputation Survey；
invited expert for the 2022 and 2024 Times Higher Education China Discipline Rating Reputation Survey；A council member of the Clinical Pharmacy Branch of the Chinese Society of Traditional Chinese Medicine Information;
vice Chairman of the Chinese Herbal Medicine Branch of Guangdong Health Association;
the member of European Atherosclerosis Society;
Has worked at Pusan National University, Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences, and Technical University of Munich;
Has served as the editorial board members or young editorial board members for ten journals, including Interdisciplinary Sciences: Computational Life Sciences（IF=4.8, Q1）, Metabolism and Target Organ Damage (ESCI, 3.6), Epigenetics Insights (ESCI, 3.2),  plos one journal (IF=2.9, Q1); has reviewed for 50 international journals，including Burn& trauma, Journal of ethnopharmacology; has published nearly 70 papers, including Aging research reviews (IF=13.1), phytomedicine (IF=7.9), Frontier in Pharmacy (IF=5.8), International immnopharmacology (IF=5.6), and Chemical biological practice (IF=5.1); has 7 invention patents, 3 utility model patents, and obtained one clinical approval for small molecule innovative drugs.

Cell Biology Clinical Trials Developmental Biology Epidemiology Infectious Diseases